+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tranexamic"

From
From
From
From
Antifibrinolytic Drugs Market - Forecasts from 2020 to 2025 - Product Thumbnail Image

Antifibrinolytic Drugs Market - Forecasts from 2020 to 2025

  • Report
  • April 2020
  • 115 Pages
  • Global
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Tranexamic acid is a hematological drug used to treat and prevent excessive bleeding. It is a synthetic derivative of the amino acid lysine and is used to reduce the breakdown of blood clots. It is commonly used to treat heavy menstrual bleeding, nosebleeds, and bleeding after surgery or childbirth. It is also used to reduce the risk of bleeding in people with hemophilia and other bleeding disorders. Tranexamic acid is available in both oral and intravenous forms. Tranexamic acid is a widely used hematological drug, with a variety of applications in the treatment and prevention of excessive bleeding. It is used in a range of medical settings, from emergency care to long-term management of bleeding disorders. Companies in the tranexamic market include Pfizer, Sanofi, Novartis, Bayer, and Teva Pharmaceuticals. Show Less Read more